scholarly journals LOW-DOSE DAILY ORAL METRONIDAZOLE IS ASSOCIATED WITH A REDUCTION IN MALIGNANT FISTULAE IN LOCALLY RECURRENT CERVICAL CANCER: RESULTS FROM A TEN-YEAR HISTORIC COHORT

Author(s):  
Reena Mary George ◽  
Thotampuri Shanthi Prasoona ◽  
Ramu Kandasamy ◽  
Thenmozhi Mani ◽  
Roja Rekha ◽  
...  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Chia-Hao Liu ◽  
Yen-Hsuan Kung ◽  
Jeff Chien-Fu Lin ◽  
Chi-Mu Chuang ◽  
Hua- Hsi Wu ◽  
...  

2004 ◽  
Vol 14 (5) ◽  
pp. 846-851 ◽  
Author(s):  
V. Moutardier ◽  
G. Houvenaeghel ◽  
M. Martino ◽  
B. Lelong ◽  
V. J. Bardou ◽  
...  

1994 ◽  
Vol 52 (3) ◽  
pp. 332-336 ◽  
Author(s):  
Hans Ikenberg ◽  
Christian Spitz ◽  
Beate Schmitt ◽  
Jakobus Pfisterer ◽  
Ulrich Aisslinger ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Xiang Zhang ◽  
Zhongbo Chen ◽  
Jianhong Chen ◽  
Junjian Wang ◽  
Yingchang Wang ◽  
...  

2021 ◽  
Author(s):  
Wen Zou ◽  
Minjie Shan ◽  
Tao Hou ◽  
Yanlong Li ◽  
Yeqian Feng ◽  
...  

Abstract Background: Salvage radiotherapy modes for treating patients with local cervical cancer recurrence after radical surgery are controversial. Therefore, we aimed to evaluate the clinical efficacy and prognostic significance of two radiotherapy modes—involved-field radiotherapy combined with regional lymph nodes (regional radiotherapy) and involved-field radiotherapy alone (local radiotherapy)—in these patients.Methods: We retrospectively enrolled patients with local recurrence who underwent radical surgery without radiotherapy for early-stage cervical cancer from January 2010 to January 2020. Clinical outcomes were analyzed using the Kaplan–Meier method and a Cox proportional hazards model.Results: Forty-four patients underwent intensity-modulated radiotherapy (IMRT)-based salvage treatment. The 5-year overall survival and progression-free survival rates were 64% and 60.2%, respectively. Sixteen of 18 patients with stump recurrence and 15 of 26 patients with pelvic and abdominal cavity recurrence received regional radiotherapy, while others received local radiotherapy. Univariate analysis showed that patients with stump recurrence, who underwent regional radiotherapy, and with a lower systemic inflammation response index (SIRI) had better prognosis than their counterparts. Patients aged < 51 years, with stump recurrence, recurrence time ≤ 24 months, recurrence site=1, and a lower SIRI who received regional radiotherapy had a better prognosis than patients who received local radiotherapy. SIRI correlated with the recurrence site and radiotherapy mode.Conclusion: Locally recurrent cervical cancer treated with IMRT-based salvage therapy has a good prognosis. Recurrence site, SIRI, and the radiotherapy mode significantly influenced prognosis. Regional radiotherapy may be suitable for patients with stump recurrence, recurrence time ≤ 24 months, and one recurrence site.


Sign in / Sign up

Export Citation Format

Share Document